- Previous Close
0.1333 - Open
0.1333 - Bid 0.1310 x --
- Ask 0.1403 x --
- Day's Range
0.1333 - 0.1333 - 52 Week Range
0.0400 - 0.2563 - Volume
25,000 - Avg. Volume
13,606 - Market Cap (intraday)
13.937M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.
pharmala.caRecent News: MDXXF
View More
Performance Overview: MDXXF
Trailing total returns as of 3/24/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDXXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDXXF
View MoreValuation Measures
Market Cap
13.87M
Enterprise Value
13.73M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
50.01
Price/Book (mrq)
10.48
Enterprise Value/Revenue
57.82
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: MDXXF
MDXXF does not have Company Insights